[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Medicus Pharma Ltd (MDCX)

Medicus Pharma Ltd (MDCX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 26,063
  • Shares Outstanding, K 56,658
  • Annual Sales, $ 0 K
  • Annual Income, $ -35,460 K
  • EBIT $ -38 M
  • EBITDA $ -38 M
  • 60-Month Beta -0.05
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 12.19
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.21
  • Most Recent Earnings $-0.31 on 05/14/26
  • Next Earnings Date 08/10/26
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.14
  • Number of Estimates 2
  • High Estimate $-0.12
  • Low Estimate $-0.15
  • Prior Year $-0.43
  • Growth Rate Est. (year over year) +67.44%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3020 +45.70%
on 06/11/26
0.4922 -10.61%
on 06/30/26
+0.0900 (+25.71%)
since 06/05/26
3-Month
0.2500 +76.00%
on 05/05/26
0.4974 -11.54%
on 04/08/26
-0.0100 (-2.22%)
since 04/07/26
52-Week
0.2500 +76.00%
on 05/05/26
3.6900 -88.08%
on 07/08/25
-2.9600 (-87.06%)
since 07/07/25

Most Recent Stories

More News
New to The Street Show #760 Airs Tonight on Bloomberg Television Across the U.S. on Independence Day Featuring Sullivan & Cromwell’s Frank Aquila, Medicus Pharma, PetVivo, FreeCast and YY Group

Honoring Economic Freedom and American Capitalism Through Television That Connects Markets, Entrepreneurs, and Investors

CAST : 3.50 (-13.58%)
PETV : 0.8191 (+2.39%)
LTRN : 3.57 (-9.16%)
MDCX : 0.4400 (-4.35%)
YYGH : 1.5000 (-4.46%)
BSIN : 1.1300 (+0.89%)
DVLT : 0.3518 (-3.67%)
Medicus Pharma to Showcase SkinJect® Registrational Strategy and Teverelix® Precision Medicine Program at Bio International 2026

PHILADELPHIA, June 22, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) (“Medicus” or the “Company”), a biotech/life sciences company focused on advancing the clinical development...

MDCX : 0.4400 (-4.35%)
New to The Street broadcasts show #758 TODAY AT 6:30 PM ET on BLOOMBERG TELEVISION ACROSS THE UNITED STATES, LATIN AMERICA, AND MENA

Featured Interviews Include Aeries Technology (NASDAQ: AERT), Virtuix Holdings (NASDAQ: VTIX), and EmpowerLit; Sponsored Programming Supported by DataVault AI (NASDAQ: DVLT), IGC Pharma (NYSE American:...

IGC : 0.2780 (-1.07%)
VTIX : 2.93 (-6.39%)
AERT : 7.35 (+2.08%)
MDCX : 0.4400 (-4.35%)
NRXP : 4.16 (+5.45%)
DVLT : 0.3518 (-3.67%)
Medicus Pharma Announces U.S. Food and Drug Administration (FDA) Submission of Rare Pediatric Disease Designation Request for SkinJect® in Gorlin Syndrome

PHILADELPHIA, June 15, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) (“Medicus” or the “Company”), a biotech/life sciences company focused on advancing the clinical development...

MDCX : 0.4400 (-4.35%)
New to The Street Broadcasting Saturday June 13th 630pm est ACROSS BLOOMBERG TELEVISION IN THE U.S., LATIN AMERICA, AND MENA

Brent Lucas, CEO of Envoy Medical (NASDAQ:COCH), Discusses the Company's Breakthrough Fully Implanted Hearing Device Designed to Deliver 24-Hour Hearing

RDZN : 1.2700 (-7.30%)
IGC : 0.2780 (-1.07%)
MDCX : 0.4400 (-4.35%)
DVLT : 0.3518 (-3.67%)
COCH : 0.7600 (-4.47%)
Medicus Pharma Initiates Groundbreaking PRECISION-E2 Phase 2a Study of Teverelix® in Endometriosis utilizing the Emirati Genome Program

PHILADELPHIA, June 11, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) (“Medicus” or the “Company”), a biotech/life sciences company focused on advancing the clinical development...

MDCX : 0.4400 (-4.35%)
Medicus Pharma Advances Teverelix® Program Towards Registrational Development Targeting High Cardiovascular-Risk Prostate Cancer Patients with Key European Submission

PHILADELPHIA, June 08, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) (“Medicus” or the “Company”), a biotech/life sciences company focused on advancing the clinical development...

MDCX : 0.4400 (-4.35%)
New to The Street Broadcasts Tonight on Bloomberg Television Across the United States, Latin America, and MENA at 6:30 PM ET

Featured Interviews Include Envoy Medical (NASDAQ:COCH), Big Sky Industrial (NASDAQ:BSIN), Graphene Manufacturing Group (OTCQX:GMGMF), Gold Royalty Corp. (NYSE American:GROY), and New York City's Acclaimed...

RDZN : 1.2700 (-7.30%)
CAST : 3.50 (-13.58%)
GROY : 2.65 (-5.02%)
GMGMF : 1.6850 (-1.63%)
LTRN : 3.57 (-9.16%)
MDCX : 0.4400 (-4.35%)
BSIN : 1.1300 (+0.89%)
DVLT : 0.3518 (-3.67%)
COCH : 0.7600 (-4.47%)
Medicus Pharma Advances SkinJect® into Registrational Development for Gorlin Syndrome

PHILADELPHIA, June 03, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) (“Medicus” or the “Company”), a biotech/life sciences company focused on advancing the clinical development...

MDCX : 0.4400 (-4.35%)
New to The Street Broadcasts Nationwide on Bloomberg Television Featuring "Opportunities To Consider(TM)" Across Artificial Intelligence, Healthcare Innovation, Fintech, Digital Assets, and Commodities

NEW YORK CITY, NY / ACCESS Newswire / May 30, 2026 / New to The Street announces tonight's Bloomberg Television broadcast airing at 6:30 PM ET as sponsored programming across the United States, MENA, and...

RDZN : 1.2700 (-7.30%)
HIT : 1.0400 (+6.66%)
GROY : 2.65 (-5.02%)
IGC : 0.2780 (-1.07%)
LTRN : 3.57 (-9.16%)
MDCX : 0.4400 (-4.35%)
DVLT : 0.3518 (-3.67%)

Business Summary

Medicus Pharma Ltd is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutics assets. Medicus Pharma Ltd is based in Toronto, Ontario.

See More

Key Turning Points

3rd Resistance Point 0.4892
2nd Resistance Point 0.4716
1st Resistance Point 0.4558
Last Price 0.4400
1st Support Level 0.4224
2nd Support Level 0.4048
3rd Support Level 0.3890

See More

52-Week High 3.6900
Fibonacci 61.8% 2.3759
Fibonacci 50% 1.9700
Fibonacci 38.2% 1.5641
Last Price 0.4400
52-Week Low 0.2500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.